RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
GeneReach Biotechnology - Stock

GeneReach Biotechnology ROA 2024

GeneReach Biotechnology ROA

-0.14

Ticker

4171.TWO

ISIN

TW0004171004

In 2024, GeneReach Biotechnology's return on assets (ROA) was -0.14, a -203.59% increase from the 0.14 ROA in the previous year.

GeneReach Biotechnology Aktienanalyse

What does GeneReach Biotechnology do?

GeneReach Biotechnology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding GeneReach Biotechnology's Return on Assets (ROA)

GeneReach Biotechnology's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing GeneReach Biotechnology's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider GeneReach Biotechnology's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in GeneReach Biotechnology’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about GeneReach Biotechnology Stock

What is the Return on Assets (ROA) of GeneReach Biotechnology this year?

The Return on Assets (ROA) of GeneReach Biotechnology is -0.14 undefined this year.

What was the ROA of GeneReach Biotechnology compared to the previous year?

The ROA of GeneReach Biotechnology has increased by -203.59% compared to the previous year.

What consequences do high ROA have for investors of GeneReach Biotechnology?

A high ROA is advantageous for investors of GeneReach Biotechnology, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in GeneReach Biotechnology?

A low ROA can be unfavorable for investors of GeneReach Biotechnology as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of GeneReach Biotechnology affect the company?

An increase in ROA of GeneReach Biotechnology can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of GeneReach Biotechnology impact the company?

A reduction in the ROA of GeneReach Biotechnology can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of GeneReach Biotechnology?

Some factors that can influence the ROA of GeneReach Biotechnology include revenue, operating costs, asset structure, and industry average.

Why is the ROA of GeneReach Biotechnology important for investors?

The ROA of GeneReach Biotechnology is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can GeneReach Biotechnology take to improve ROA?

To improve ROA, GeneReach Biotechnology can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does GeneReach Biotechnology pay?

Over the past 12 months, GeneReach Biotechnology paid a dividend of 1.2 TWD . This corresponds to a dividend yield of about 3.65 %. For the coming 12 months, GeneReach Biotechnology is expected to pay a dividend of 1.2 TWD.

What is the dividend yield of GeneReach Biotechnology?

The current dividend yield of GeneReach Biotechnology is 3.65 %.

When does GeneReach Biotechnology pay dividends?

GeneReach Biotechnology pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of GeneReach Biotechnology?

GeneReach Biotechnology paid dividends every year for the past 2 years.

What is the dividend of GeneReach Biotechnology?

For the upcoming 12 months, dividends amounting to 1.2 TWD are expected. This corresponds to a dividend yield of 3.65 %.

In which sector is GeneReach Biotechnology located?

GeneReach Biotechnology is assigned to the 'Health' sector.

Wann musste ich die Aktien von GeneReach Biotechnology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of GeneReach Biotechnology from 9/4/2023 amounting to 1.2 TWD, you needed to have the stock in your portfolio before the ex-date on 7/28/2023.

When did GeneReach Biotechnology pay the last dividend?

The last dividend was paid out on 9/4/2023.

What was the dividend of GeneReach Biotechnology in the year 2023?

In the year 2023, GeneReach Biotechnology distributed 3.636 TWD as dividends.

In which currency does GeneReach Biotechnology pay out the dividend?

The dividends of GeneReach Biotechnology are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von GeneReach Biotechnology

Our stock analysis for GeneReach Biotechnology Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of GeneReach Biotechnology Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.